Zenith Technologies expands US presence
![](/46/pdcnewsitem/04/23/70/Mike%20Smith.jpg)
Mike Smith, US sales manager, Zenith Technologies.
Expansion is the result of the demand for the company's automation, process control and serialization technology services.
Zenith Technologies is expanding its US presence by opening two new offices on the West Coast of the US to meet greater demand for its automation, process control and serialization technology support services.
Marking 10 years since the company first opened a US base in Pennsylvania, the new sites in Oakland and San Diego will help the life science technology firm deliver a more localized service to its North American customers.
Zenith Technologies’ clients range from small and mid-sized pharma and biotech companies to contract manufacturing organisations and big pharma firms.
The decision to open the new offices comes following an increase in demand for its automation manufacturing software systems and the significant biotech sector expansions in Southern and Northern California.
Mike Smith, US sales manager at Zenith Technologies said: “We are looking forward to bolstering our US presence with the opening of these two new sites as it means we can provide complete coverage of service in the US from coast to coast.
“Expanding into such high growth areas for the life science and biotechnology industry means it is a really exciting time for our company and a great way to mark a decade of presence in North America.”
Both offices will act as a hub for critical project aid, back office assistance and managed services, allowing Zenith Technologies to provide improved service and on-the-ground support to its customer base.
The company’s US expansion initially began as a single project in Pennsylvania in 2006 but has grown into six offices across the US and close to 100 employees servicing a diverse client base.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance